Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001185185-25-001021
Filing Date
2025-08-18
Accepted
2025-08-18 15:02:22
Documents
18
Period of Report
2025-10-10

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A igcdef14a081825.htm   iXBRL DEF 14A 386447
2 GRAPHIC image_001.jpg GRAPHIC 6278
3 GRAPHIC image_002.jpg GRAPHIC 2636
  Complete submission text file 0001185185-25-001021.txt   1013889

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE igc-20250831.xsd EX-101.SCH 9944
5 XBRL DEFINITION FILE igc-20250831_def.xml EX-101.DEF 4332
6 XBRL LABEL FILE igc-20250831_lab.xml EX-101.LAB 33805
7 XBRL PRESENTATION FILE igc-20250831_pre.xml EX-101.PRE 3200
20 EXTRACTED XBRL INSTANCE DOCUMENT igcdef14a081825_htm.xml XML 107455
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-32830 | Film No.: 251227610
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)